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 INTRODUCTION
The AS-C genes in flies comprise a set of four genes that are
ascribed proneural functions, in that their activation augments
neural deteremination (Alonso and Cabrera, 1988; Ghysen and
Dambly, 1988; Campuzano and Modollel, 1992). They code
for transcription factors of the basic-helix-loop-helix family
(bHLH; Murre et al., 1989a), and are believed to promote
neural differentiation in a manner similar to the proposed role
of the myogenic bHLH proteins, MyoD, myf-5 and myogenin,
in muscle development (Weintraub et al., 1991a). Flies that
lack all of the AS-C genes have severe neural hypoplasia both
in the central and peripheral nervous system, while ectopic
expression of the AS-C genes can lead to additional neural
differentiation (reviewed by Campos-Ortega and Jan, 1991;
Campos-Ortega, 1993).
The Xenopus genes, XASH-1 (Ferreiro et al., 1993) and
XASH-3 (Zimmerman et al., 1993) were cloned based on their
sequence homology with the Drosophila AS-C genes. MASH-
1, a mammalian AS-C homolog (Johnson et al., 1990), is
required for the development of the peripheral autonomic and
olfactory nervous system in mice (Guillemot et al., 1993).
XASH-1, named because of its homology to MASH-1, is first
expressed zygotically in the anterior neuropithelium of the
embryo during folding of the neural tube in a pattern similar
to but not identical with MASH-1 (Ferreiro et al., 1993). XASH-
3, however, can be detected much earlier, at stage 11.5, in an
area fated to become part of the neural plate, including pre-
sumptive brain and spinal areas (Zimmerman et al., 1993). This
makes XASH-3 one of the earliest expressed neural-specific
transcription factors in the Xenopus embryo. Since induction
of the neural plate by the organizer begins at the onset of gas-
trulation (Kintner, 1992; Slack and Tannahill, 1992) just an
hour and a half earlier, XASH-3 could act early during neural
induction to promote neural development.
To determine whether XASH-3 promotes neural develop-
ment in Xenopus embryos, we investigated whether XASH-3
can activate neural genes in ectoderm by injecting Xenopus
embryos with XASH-3 RNA, along with RNA encoding the
promiscuous bHLH heterodimer partner XE12. Ectodermal
caps isolated from these embryos were found to express neural
genes but not a mesoderm-specific gene. This activation of
neural genes, however, appeared to be transient, and was not
maintained in culture. The proneural activity of the XASH
genes was reinforced by the finding that the expression of
either XASH-1/XE12 or XASH-3/XE12 in embryos results in a
stable enlargement of the neural tube. Ectopic XASH
expression, however, did not cause the formation of neural
tissue in ventral regions of the embryo. These results suggested
that XASH-mediated activation of neural genes normally works
in the context of a neural inducing signal and cannot substitute
for this signal. In agreement with this idea, we found that
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Neural development in Drosophila is promoted by a family
of basic helix-loop-helix (bHLH) transcription factors
encoded within the Achaete Scute-Complex (AS-C). XASH-
3, a Xenopus homolog of the Drosophila AS-C genes, is
expressed during neural induction within a portion of the
dorsal ectoderm that gives rise to the neural plate and tube.
Here, we show that XASH-3, when expressed with the
promiscuous binding partner XE12, specifically activates
the expression of neural genes in naive ectoderm, suggest-
ing that XASH-3 promotes neural development. Moreover,
XASH-3/XE12 RNA injections into embryos lead to hyper-
trophy of the neural tube. Interestingly, XASH-3 misex-
pression does not lead to the formation of ectopic neural
tissue in ventral regions, suggesting that the domain of
XASH proneural function is restricted in the embryo. In
contrast to the neural inducer noggin, which permanently
activates the NCAM gene, the activation of neural genes by
XASH-3/XE12 is not stable in naive ectoderm, yet XASH-
3/XE12 powerfully and stably activates NCAM, Neurofila-
ment and type III β-tubulin gene expression in noggin-
treated ectoderm. These results show that the XASH-3
promotes neural development, and suggest that its activity
depends on additional factors which are induced in
ectoderm by factors such as noggin. 
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neurogenesis, Xenopus
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XASH-3/XE12 was a much more efficient activator of neuronal
differentiation in noggin induced ectoderm. These results
support the notion that the XASH genes are proneural in
Xenopus, and that XASH-3 proneural activity in the early neu-
roectoderm is enhanced by neural induction. 
MATERIAL AND METHODS
Whole embryo analysis
cDNAs for XASH-1 and XASH-3 were subcloned into sp64T and tran-
scribed into capped mRNA in vitro using SP6 polymerase (Kreig and
Melton, 1987). One blastomere of 2-cell or 4-cell stage embryos were
injected with 5 nl of mRNA solution. All injection solutions contained
80 pg β-gal mRNA (for doses of other RNAs see text and figure
legends). In those cases where XASH RNA and XE12 RNA (Rashbass
et al., 1992) were injected together, they were mixed and added to the
β-gal mRNA. Embryos were fixed in 4% paraformaldehyde, 15-36
hours after the injections, all were stained for β-gal activity with X-
gal, and some were stained for NCAM or Xtwist message using a
whole-mount protocol (Harland, 1991). The whole-mount embryos
were cleared in benzyl-benzoate (Harland, 1991) causing the β-gal
staining to fade eventually. Some of the embryos were embedded in
paraffin for sectioning. 
Animal cap studies
Both blastomeres of 2-cell stage embryos were injected with 5 nl of
mRNA solution including the types and amounts described below.
Noggin mRNA (Lamb et al., 1993) was generated from a PCR product
corresponding to the noggin cDNA that was subcloned into sp64T.
Six animal caps per condition were dissected out and cultured for 24
hours (or until undissected siblings reached N/F stage 24/25) on 1%
agarose dishes in 0.5× MMR plus antibiotics. RNA was isolated from
the cultured caps or from 3 control embryos and divided into a 90%
portion, used for the RNase protection assay of the expression of NF,
type III β-tubulin, NCAM and EF-1A, and a 10% portion, used for the
RNase protection assay of the expression of muscle-specific actin.
Probes are described in detail by Dixon and Kintner (1989) and Lamb
et al. (1993). Approximately equivalent amounts of animal cap RNA
were assayed in each case as monitored by the levels of EF1α tran-
scripts or the cross-hybridization with cytoskeletal actin. 
RESULTS
The effect of XASH-3 on the expression of neural-
specific genes in uninduced animal caps
Animal cap tissue isolated from the late blastula normally dif-
ferentiates into epidermis but can be induced to become meso-
dermal or neural tissue if combined with a source of appropri-
ate inducing signals (Kintner and Melton, 1987; Sharpe et al.,
1987; Dixon and Kintner, 1989; Green and Smith, 1991). In
order to determine whether XASH-3 promotes neural develop-
ment in ectoderm in the absence of neural inducing signals,
animal caps were isolated from embryos injected at the one or
two cell stage with XASH-3, cultured overnight, and then
assayed for the expression of several neural-specific genes by
an RNAase protection assay. Animal caps from embryos
injected with just XASH-3 alone (Fig. 1, lane d) expressed only
very small amounts of the neural-specific transcript NCAM.
Since XASH-3, like other bHLH transcription factors, is likely
to act as a heterodimer with the promiscuous bHLH partner
E12, the vertebrate homolog of da (which may be in limiting
quantity in the embryo; Lassar et al., 1989; Murre et al., 1989b;
Rashbass et al., 1992), XASH-3 RNA was injected along with
low amounts of XE12 (Rashbass et al., 1992). Caps isolated
from these embryos expressed NCAM transcripts as well as
neuronal-specific transcripts for Neurofilament (NF) similar to
those present in stage-matched embryos, even though the caps
were cultured without any neural inducers (Fig. 1, top lanes e
and i). Since ectoderm from embryos injected with just XE12
or XASH-3 alone failed to express significant levels of NCAM
RNA (Fig. 1, top lanes c and d), XASH-3 and XE12 appear to
act synergistically to induce neural gene expression. 
Ectoderm from XASH-3/XE12-injected embryos was also
examined the expression of the dorsal mesodermal marker,
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Fig. 1. The specificity of expression of neural and muscle transcripts
in animal caps from embryos injected with different bHLH encoding
mRNAs. Top: 125 pg (high) but not 25 pg (low) of XE12 mRNA
induces NCAM and neurofilament expression (lanes b and c). 833 pg
of XASH-3 mRNA alone induces only slight NCAM expression, but
when it is combined with 25 pg of XE12 mRNA, there is a dramatic
increase in NCAM and NF expression (lanes d and e). Note that the
level of neural transcripts in the XASH-3/XE12-injected condition are
close to the levels in whole uninjected embryos (lane i). 833 pg of
XMyoD mRNA induces both NF and NCAM expression, but when
this is combined with 25 pg of XE12, the levels of NCAM and NF
expression are not increased (lanes f and g). Bottom: 125 pg of XE12
mRNA induces some expression of muscle-specific actin (lane b),
but neither XE12 at 25 pg orXASH-3 at 833 pg alone, or in
combination, induce muscle actin expression (lanes c-e). However,
XMyoD at 833 pg does activate muscle actin expression and this is
dramatically enhanced by combination with 25 pg of XE12 mRNA
(lanes f and g). These results were replicated twice in independent
experiments. The asterisk shows cytoskeletal actin mRNA, which is
recognized by the cardiac actin probe and acts as a loading control.
These lanes were cut and rearranged from a single exposure of one
experiment. 
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Cardiac Actin or Muscle Specific Actin (MSA; Hopwood and
Gurdon, 1990). In contrast to the clear induction of neural
genes, there was no induced expression of MSA (Fig. 1, lane
e), suggesting that the effect of XASH-3 on neural development
is direct in the sense that the neural induction it is not mediated
through the primary induction of dorsal mesoderm in these
caps. 
Specificity of MyoD/XE12 for myogenesis and
XASH-3/XE12 for neurogenesis 
In order to assess further the specificity of XASH-3, we also
examined the effects of XMyoD (Hopwood et al., 1989), a
bHLH transcription factor that was previously shown to induce
the expression of muscle-specific genes (Weintraub et al.,
1991b), and MSA expression in animal cap assays (Hopwood
and Gurdon, 1990). Surprisingly, injection of XMyoD RNA
alone induced low levels of NCAM and NF as well as MSA
RNA expression (Fig. 1, lane f). Reducing the amounts XMyoD
RNA injected into embryos, simultaneously reduced the levels
of MSA and of NF and NCAM RNA. Thus, we could not find
a dose of XMyoD RNA that induced MSA but not neural gene
expression. Previous work with XMyoD had shown that coex-
pression with XE12 results in formation of heterodimers, and
an enhancement in XMyoD’s ability to activate muscle-specific
genes (Rashbass et al., 1992). Thus, we injected embryos with
XMyoD plus XE12, at a concentration of XE12 that alone did
not induce any of the marker genes. We saw a specific
enhancement of MSA expression, and no enhancement of either
NCAM or NF expression (Fig. 3, lane g). This result is similar
to the above result with XASH-3, which when combined with
XE12, also greatly enhanced the expression of the the neural-
specific markers, but still did not cause any induction of the
muscle-specific marker (Fig. 3, lanes d and e). This indicates
that, in the presence of XE12, XASH-3 is a specific activator of
neural gene expression while XMyoD is primarily an activator
of muscle gene expression. 
It is not clear why XMyoD RNA injected alone activates low
levels of NCAM and NF RNA expression. We noted, however,
that animal caps isolated from embryos injected with five times
the dose of XE12 RNA (125 pg instead of 25 pg) also expressed
RNAs for neural-specific genes as well as MSA (Fig. 3, lane
b). Misexpression of bHLH proteins may have indirect effects
because of their propensity to heterodimerize indiscriminately,
and to dilute out potential inhibitors such as id (Benezra et al.,
1990) or activators such as E12. (Parkhurst et al., 1990; Jarman
et al., 1993). Since XASH-3 binds the mammalian muscle
creatine kinase (MCK) E-box in vitro and transactivates the
MCK/CAT reporter gene in transfected 10T1/2 cells
(Zimmerman et al., 1993), it is perhaps surprising that XASH-
3 activates neural gene expression but not muscle gene
expression in vivo. This suggests that XASH-3 is not a promis-
cuous in vivo, and that it may show this particular specificity
in the context of unidentified factors that exist in cells of the
developing embryo.
Activation of neural gene expression in animal caps
by XASH-3 is unstable 
Activation of neural gene expression by XASH-3 suggests that
XASH-3 promotes neural differentiation. Similar studies using
injection of XmyoD RNA, however, have shown that XMyoD
can activate muscle gene expression in animal cap assays
without causing the differentiation of ectoderm cells into
muscle (Hopwood and Gurdon, 1990). In the case of XMyoD,
muscle gene expression can be detected in ectoderm after 1 day
in culture, but the expression is then lost, presumably following
the loss of the misexpressed XMyoD transcripts and protein.
Similarly, ectoderm from embryos injected with XASH-3/
XE12, after 1 day in culture, expressed large amounts of NCAM
and NF RNA, but after 2-3 days in culture, the levels of these
RNAs dropped, and in some experiments disappeared alto-
gether (Fig. 2). These results indicate that while XASH-3 can
activate neural gene expression in naive ectoderm, XASH-3 is
probably not acting as a switch, causing cells that express it
transiently to become neural. In this sense, the injection of
XASH-3/XE12 RNA does not mimic the normal events of
neural induction. This result also agrees with our whole
embryo misexpression studies (see below), and indicates that
XASH-3 probably does not activate neural genes by inducing
a neural inducer, as all neural inducers so far studied stably
activate neural development.
The effect of XASH-3 in animals caps is very sensitive to
concentration. Relatively large amounts of XASH-3/XE12
RNA are needed to turn on neural gene expression, yet when
the XASH-3 RNA has been diluted out even 2- to 3-fold, there
is little or no activation (data not shown). The sharp dose
response curve is consistent with the idea that XASH-3 acts by
activating its own expression as has been proposed for the
myogenic bHLH transcription factors (Weintraub et al.,
1991a). XASH-3 injection, however, does not appear to turn on
XASH-1 expression in isolated ectoderm (data not shown) sug-
gesting that cross-regulation between the XASH genes may not
be a factor in this dosage sensitivity.
XASH genes in embryos lead to neural hypertrophy
in dorsal regions of the embryo 
To explore the role of XASH genes in neural development in
vivo, we examined the phenotypes of embryos that had been
exposed to ectopic XASH-1 and XASH-3 by RNA injection.
When embryos were injected with the same levels of XASH-
Fig. 2. XASH3/XE12
transiently activates
neural genes.
Neurofilament and
NCAM are induced
strongly in naive
ectoderm by the
injection of XASH-
3/XE12 when the caps
are assayed 1 day after
the injection (lane a). If
the caps are cultured for
a second or third day, the
level of these neural
genes is dramatically
reduced (lane d). Control
caps (lanes b and e)
show no neural gene
expression on day 1 or 2.
This experiment was
repeated at least three times, and although there was some variation in
the extent of the decrease in NCAM and NF expression XASH-3/XE12
induced caps, the decrease was always dramatic by 3 days. 
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3/XE12 RNA that led to the activation of neural genes in the
animal cap assay, they failed to gastrulate normally and thus
could not be analyzed. Therefore, we examined embryos that
had been injected with a ten-fold dilution of XASH-3 RNA. At
this dose, XASH-3/XE12 did not have any effect on neural gene
expression in the animal cap assay (see below). However,
when these embryos were allowed to develop until neural plate
or neural tube stages, they showed extra neural tissue when
they were examined both histologically and for the expression
of the neural-specific gene NCAM. (Fig. 3A,C). Histological
analysis reveals that the neural plate of younger embryos and
the neural tube of older ones expands dramatically on the
injected side, spreading out laterally (Figs 3C, 4). No
expansion of the notochord was observed (Fig. 3C), nor was
there enhanced expression of the notochord-specific gene
Xlim-1 (Taira et al., 1992) (data not shown). Similar, though
less dramatic, results were obtained with XASH-1/XE12 injec-
tions (Figs 3D, 4). This, combined with the evidence from
animal caps above, confirms that the expansion of the neural
tube is not a secondary consequence of the XASH genes leading
to extra inducing tissue on the injected side. In addition, the
expansion of the neural tube is not simply the result of injecting
the XE12 molecule. We also looked at embryos in which XE12
was injected alone at twice the dose of the XASH-3/XE12
experiments and in no case did we see an expansion of the
neural tube (Fig. 4). Thus, XASH RNA can perturb the amount
of neural tissue that forms in embryos at doses where it has no
effects on isolated animal cap tissue. 
Importantly, the enlargement of neural tissue following the
injection of low amounts of XASH-3/E12 RNA was
autonomous and restricted. Neural hypertrophy was only in the
side of the embryo where the ectopic XASH-3/XE12 was
expressed, and only in the region of the neural plate/tube. If,
for instance, XASH-3/XE12 was expressed in the posterior part
of the embryo, then the neural plate would expand only in the
region of ectopic expression. When XASH-1/XE12 or XASH-
3/XE12 was misexpressed in ventral regions of the embryo,
this did not lead to an extra neural tissue, suggesting that the
proneural function of XASH is restricted to the dorsal
ectoderm, near its normal zone of expression. 
Since the lateral expansion of the neural tube could be at the
expense of tissue around the neural plate, we looked at the
ectodermal expression of Xtwist, a cephalic neural crest
marker, expressed at the lateral borders of the anterior neural
plate (Hopwood et al., 1989). Consistent with this idea,
embryos misexpressing XASH-3/XE12 showed reduced Xtwist
expression on the injected side (Figs 3B, 4). Similar results on
the expansion of the neural tube at the expense of lateral
ectoderm in XASH-3 injected embryos have been found by
Turner and Weintraub (1994). 
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Fig. 3. Phenotypes of XASH/XE12-injected embryos. (A). Direct dorsal view of a whole-mount embryo injected with 90 pg ofXASH-3 mixed
with XE12 in the right side (anterior to right), and stained for the expression of NCAM mRNA by in situ hybridization (Harland, 1991). The
neural tissue on the injected side (brackets) is obviously much wider along its entire length including hindbrain (hb) and spinal cord (sc) than
that on the uninjected side. (B) Direct dorsal view of a late neural plate embryo shows a striking reduction in ectodermal Xtwist expression (in
white boxes) on the XASH-3/XE12-injected right side (brackets). Anterior (a) is to the right. (C) A section through the spinal region of an
embryo like that in A. In this section, also labeled for NCAM expression, we note the lateral expansion (between arrowheads) of the neural
tissue on the injected right side (brackets). The normally sized notochord (nc), marking the midline, is visible directly below the neural tube
(nt). (D) Expansion of the neural tube (nt) in a XASH-1/XE12-injected embryo. Here the tube was photographed using Nomarski optics. The
white vertical bar marks the midline of the neural tube. 
A B
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XASH-3 promotes neuronal differentiation in
noggin-treated animal caps
The result described above indicates that XASH-3 can promote
neural development but only in regions of the embryo where
neural induction normally takes place. To test this further, we
examined the effects of XASH-3 expression in ectoderm that
had been induced to form neural tissue by the neural inducer
noggin (Lamb et al., 1993). Noggin-treated ectoderm expresses
large amounts of NCAM RNA as well as the anterior CNS
homeodomain transcript OtxA (Lamb et al., 1993). In contrast
to XASH-3-expressing ectoderm, however, noggin-induced
ectoderm does not appear to undergo neuronal differentiation
as marked by the expression of neuronal genes such as type III
neural-specific tubulin (Lamb et al., 1993). Thus, we injected
XASH-3/E12 RNA along with noggin RNA into animal caps
and assayed for type III tubulin expression. The results of this
analysis shows that noggin-injected ectoderm does not express
type III tubulin (Fig. 5 lane 2), as shown previously (Lamb et
al., 1993). However, when these caps are co-injected with
XASH-3/E12, they express type III tubulin at levels near those
of control embryos (Fig. 5 lanes 4 and 5). Importantly, the
levels of XASH-3 required for the induction of neural tubulin
in noggin induced ectoderm are at least 10-fold less than the
levels required to induce tubulin in naive ectoderm, and similar
to the levels required to cause neural expansion in whole
embryos. When this amount of XASH-3/XE12 RNA is injected
without noggin, there is no induction of either NCAM or
tubulin (Fig. 5 lane 3). In addition, the effects of XASH-3/XE12
expression on tubulin expression in noggin induced caps
appears to be stable for up to 2 days in culture (data not shown).
Thus, these results support the idea that XASH-3 is more
effective in promoting neural development in the context of
noggin-induced ectoderm than it is in uninduced ectoderm. 
DISCUSSION
The principle finding of this study is that XASH-3 acts as a
proneural gene. In embryos, XASH-3/XE12 results in an
increase in the size of the neural tube, perhaps by increasing
the lateral extent of the neural plate. In the animal cap assay,
XASH-3 when combined with XE12 induces neural but not
muscle gene expression. Thus, these assays provide strong
support for the conclusion that XASH-3 is a proneural gene.
Our results with misexpression corroborate the proneural role
of the vertebrate AS-C homologs that has been suggested by
the knock out of MASH-1 in the mouse (Guillemot et al., 1993). 
In overexpression studies with bHLH proteins, the question
of specificity must arise. Because bHLH genes heterodimerize,
they may have non-specific effects when overexpressed. The
classic example of this is the effect of hairy on sex determi-
nation in flies (Parkhurst et al., 1990). Thus, in the context of
the whole organism, where a myriad of bHLH proteins may be
operating in a dosage sensitive way, the overexpression of a
single member of this class can create a phenotype which may
be less informative about the overexpressed gene than it is
about its partner. We found that either XmyoD and XE12, when
expressed alone in animal caps at high enough levels, lead to
the expression of both neural and muscle-specific markers.
Why either turns on neural genes in the animal cap assay is
unclear. Perhaps they have less target specificity as homod-
imers, perhaps they are diluted out or compete with an endoge-
Fig. 5. XASH-3/XE12
efficiently induces neural
genes in noggin caps. Animal
caps from embryos injected
with noggin RNA are induced
to express NCAM, but not the
more differentiated neural
marker type III β-tubulin
(lane b). Low doses (90 pg) of
XASH-3 mixed with XE12
induce neither (lane c). When
noggin RNA is combined
with the low dose of XASH-
3/XE12, the result is the
induction of NCAM and β-
tubulin that mimic the levels
in normal embryos (lanes d
and e).
Fig. 4. Phenotypic penetrance of injected embryos. Percentages of
embryos injected unilaterally that express the neural hypertrophy and
the Xtwist reduction phenotypes in one experiment. XASH-3/XE12
strongly produced both phenotypes in a high fraction of the embryos
studied. XASH-1/XE12 injections were less effective. Small numbers
on top of the bars indicate numbers of embryos studied in each
condition. For these experiments, embryos at the two- or four-cell
stage were injected with the mRNAs listed, in combination with β-
gal mRNA. They were fixed in paraformaldehyde when they reached
neural plate through neural tube stages, stained with X-gal, and then
paraffin sectioned. If the embryo showed clear unilateral blue
staining in the region of the neural plate or tube, it was then
determined whether there was an obvious expansion of this tissue on
the injected side. For the Xtwist phenotype, similarly injected
embryos were simultaneously stained for β-gal activity and Xtwist
expression by in situ hybridization (Harland, 1991). A reduction of
Xtwist staining on the β-gal expression side was counted as a
positive. The experiment looking at enlargement of the neural tube
with XASH-3/E12 was carried out at least four times with five or
more embryos, and in each case all the misexpressing embryos
showed neural hypertrophies.
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nous inhibitory protein (Benezra et al., 1990; Ellis et al., 1990;
Garrell and Modolell, 1990; Ruezinsky et al., 1991), or perhaps
they form activating heterodimers with the low levels of
maternal XASH-1 (data not shown). The problem of specificity
is overcome to some extent in the animal cap studies where a
direct comparison of several different bHLH members can be
made on exactly the same tissue. Thus, when XASH-3 or
XMyoD were combined with low doses XE12 (at doses where
XE12 did not by itself activate neural or muscle genes), we
found that XASH-3/XE12 heterodimers strongly induce neural
genes without inducing muscle genes, while XMyoD/XE12 het-
erodimers preferentially activate myogenic genes over neural
genes. The heterodimers thus show exquisite tissue specificity
that presumably reflects their normal site of action. 
Another major finding to emerge from these studies is that
the ability of XASH-3 to act in naive ectoderm appears to be
compromised relative to its ability to act in the embryo or in
noggin-induced ectoderm. Thus, while XASH-3 will turn on
neural genes in naive ectoderm, this occurs only when rela-
tively large amounts of XASH-3 RNA are injected and in most
experiments, the effects on neural gene expression is only
transient. In contrast, 10-fold less XASH-3 RNA is required to
expand the neural tube in embryos or to activate neuronal gene
expression in noggin-induced ectoderm, and in both cases, the
effects appear to be irreversible. These observations strongly
suggest that the normal expression of XASH-3 is not sufficient
to allow ectoderm to take on the neural fate. Neural induction,
therefore, cannot be viewed simply as the activation of XASH-
3 expression.
One of the important unresolved questions raised by these
studies, concerns where XASH-3 normally acts during the early
stages of neural development. In this respect, it is interesting
to compare the effects obtained by the expression of XASH-3
in ectoderm with those obtained by treating ectoderm with the
neural inducer, noggin. While ectoderm treated with noggin
appears to differentiate into neural tissue as measured by the
expression of large amounts NCAM RNA, it does not appear
to undergo neuronal differentiation as measured by the
expression of genes such as NF or tubulin (Lamb et al., 1993).
In contrast, ectoderm injected with large amounts of XASH-
3/XE12 RNA goes on to express large amounts of both NF and
tubulin RNA relative to the amounts of the neural marker
NCAM. Moreover, tubulin expression can be activated in
noggin-treated caps even by relatively low levels of XASH-
3/XE12 RNA. Thus, one model based on these observations is
that XASH-3 acts downstream of neural induction to promote
neuronal differentiation. In this model, the primary role of the
proneural XASH genes is not to establish the neuroepithelium
of the neural plate and tube, but rather to act within this region
of the embryo to promote the neuronal fate. 
In Drosophila, Notch mutant embryos make neural tissue at
the expense of ventral epidermis, suggesting that the cells of
the ventral neurogenic region may flip between these two states
(Artavanis-Tsakonas and Simpson, 1991). Yet in mutants for
AS-C, although there is a severe neural deficiency, there is no
noticeable extra epidermal tissue (Wieschaus et al., 1984;
Jimenez and Campos-Ortega, 1990). In AS-C/Notch double
mutants, the neural hypertrophic phenotype is repressed, yet
these embryos still cannot make ventral epidermis (Martinez
Arias, 1993). These results suggest that AS-C function is not a
simply a switch between the epidermal and neural state, and
show that the lack of AS-C function does not lead cells to take
on an epidermal fate. While we have no data on the loss of
XASH function, we note that loss of MASH-1 in the mouse
leads to a loss of the olfactory neurons, but not to the neu-
roepithelium from which these neurons arise. From these data,
we suggest that the loss of XASH-3 may not cause cells in the
neural plate to take on an epidermal fate, but rather to differ-
entiate into an alternative fate within the neural tube such as,
for example, into ependymal cells.
Our studies are directly comparable to overexpression studies
in flies, using a heat shock promoter to induce the temporary
expression of scute throughout the developing fly deficient for
the endogenous achaete and scute gene function (Rodriguez et
al., 1990). One finding from such studies concerns the redun-
dancy of the AS-C genes, such that heat shock expression of
one of them can substitute for the expression of another. Thus,
sensory bristles that are lost in achaete mutants are regained in
these flies where scute or asense are ubiquitously expressed
through heat shock (Rodriguez et al., 1990; Dominguez and
Campuzano, 1993). Like the AS-C genes, the two XASH genes
are expressed in distinct but overlapping spatiotemporal
domains, yet either one has the potential, when overexpressed,
to cause neural hypertrophy, suggesting that they also may have
functional redundancy. 
A critical comparison between our results and and those in
the fly concerns the finding that the AS-C genes can only
function in restricted regions of neurogenic potential, so that
even when there is ubiquitous heat-shock induced expression
of one of these genes, sensory organs still tend to appear only
at their appropriate sites on the fly (Rodriguez et al., 1990;
Dominguez and Campuzano, 1993). The spacing between
sensory bristles is regulated in part by the inhibitor of AS-C
function, emc (Ellis et al., 1990; Garrell and Modolell, 1990).
As a HLH protein lacking a basic domain, emc has an anti-
neural function: it inactivates AS-C proteins by forming ‘dead’
heterodimers with them that are incapable of binding DNA
(Ellis et al., 1990; Garrell and Modolell, 1990). In emc mutants,
heat shock induced AS-C activity leads to ectopic bristles, sug-
gesting that the spatial restriction of AS-C proneural function
in these flies is in part controlled by the endogenous pattern of
emc expression (Cubas and Modolell, 1992). We have previ-
ously shown that emc similarly inhibits the XASH-1 DNA
binding in vitro (Ferreiro et al., 1993). Similarly, in the blas-
toderm there appears to negative regulation of the AS-C genes
by twist and snail in ventral region during establishment of the
mesoderm (Kosman et al., 1991), and in dorsal regions through
the action of dpp during the establishment of the dorsal
epidermis (Ferguson and Anderson, 1992). Thus, the dorsal
restriction we see in the proneural function of overexpressed
XASH, in Xenopus embryos could in part be due to the
expression of inhibitory factors in ventral regions of the
embryo. Neural induction may therefore not only turn on
XASH-3 expression, but also eliminate negative regulators
thereby providing a domain in which the proneural properties
of XASH-3 are effective. We cannot, of course, rule out the
possibility that there may be spatially restricted proneural
factors co-expressed with XASH-3 in the neural plate and tube
that help to turn on neural genes. 
In sum, these studies suggest that XASH-3 plays a role in
amphibian embryos in promoting neural development during
the progression of ectoderm into neural tissue. It will be of
B. Ferreiro and others
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interest to determine what factors are normally responsible for
activating XASH gene expression within the neural plate, and
whether other genes, such as the vertebrate homologs for the
Drosophila neurogenic genes or the antineural genes, regulate
the activity of the XASH genes in the neural plate and tube. 
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